Evolution Bioscience | News & Analysis

Researchers Announce ViroCap Test Capable of Detecting Nearly All Infectious Viruses

Last month researchers at Washington University in St. Louis announced the ongoing development of ViroCap, a novel test capable of detecting nearly all viruses known to infect humans and animals.

News & Analysis

Thermo Fisher and Illumina Prepare for Round Two of the Next-Gen Sequencing Battle

Earlier this month Thermo Fisher Scientific announced the launch of two novel next-generation sequencing (NGS) instruments, the Ion S5 and the Ion S5 XL benchtop systems, which combine the ability

Evolution Infographics

Evolution Analysis – Google, Sanofi, Novartis and the Race to Improve Diabetes Health Outcomes

On August 31, 2015 Google Life Sciences and French pharma giant Sanofi announced that the two companies will work together on new digital technology and tools for the treatment of

News & Analysis

Evolution Announce Human Capital Partnership with Genomics Startup QuantiHealth

Evolution Global Talent Attraction recently signed a contract to provide human capital to newly formed company QuantiHealth in China. QuantiHealth was founded by Zhao Bowen, who was named as one

Evolution Infographics

Evolution Biopharma IPO Analysis featured on Forbes

Evolution’s 2015 Biopharmaceutical IPO Analysis was featured in a recent article on Forbes. Science & Business correspondent Arlene Weintraub’s article, titled “Will Wall Street Volatility Dampen The Sizzling Biotech IPO

Evolution Infographics

Evolution Infographic – An Analysis of 2015 Therapeutic IPOs

In the first half of 2015 fifty therapeutics companies finalised their IPOs, raising over $5.17 billion across multiple global exchanges. Evolution Global Talent Attraction analysed the therapeutic targets and IPO

Evolution Infographics

Evolution Infographic – An Analysis of Biopharmaceutical Production in EMEA

Evolution Global Talent Attraction’s latest market research report looks at the capacity and content of biopharmaceutical production in Europe, the Middle East and Africa. Rather than publish a lengthy report,

News & Analysis

Record-setting IPO for cancer immunotherapy company NantKwest

NantKwest, Inc. (formerly known as Conkwest, Inc.), a clinical-stage immunotherapy company focused on harnessing the power of the innate immune system by using the natural killer cell to treat cancer,

News & Analysis

Charles River Labs to Acquire Rapid Bacterial Detection System Provider Celsis International

Preclinical CRO Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it has entered into a definitive agreement to acquire Celsis International Ltd. for $212 million in cash, subject

News & Analysis

Arysta LifeScience announce exclusive commercial partnership at Plant Impact Investors Day

Evolution Global Talent Attraction were recently invited to crop enhancement company Plant Impact’s Investors Day at Rothamsted, where Plant Impact announced the commercial launch of BANZAI, a novel product that

News & Analysis

Celgene & Juno Therapeutics announce landmark deal for CAR-T Cancer Therapies

Celgene and Juno Therapeutics have announced a decade long collaboration to advance potentially groundbreaking immunotherapies for patients with cancer and autoimmune diseases. The two companies will leverage T cell therapeutic

News & Analysis

Research Chemicals Leader Alfa Aesar to be acquired by Thermo Fisher Scientific

Thermo Fisher Scientific have signed a definitive agreement to acquire Alfa Aesar, a leading global manufacturer of research chemicals, for £256 million (approximately $405 million USD) in cash. Alfa Aesar’s

Categories

News & Analysis

AS FEATURED IN

About Us

Recent Posts